D-139 (Arsenicum album, Belladonna, Calcarea carbonica, Carbo vegetabilis, Ferrum phosphoricum, Lycopodium, Natrum phosphoricum, Nux vomica, Phosphorus, Pulsatilla, Hydrastis)
**Product type:** Human Otc Drug
**Active ingredient:** ACTIVATED CHARCOAL; ANEMONE PRATENSIS; ARSENIC TRIIODIDE; ATROPA BELLADONNA; FERROSOFERRIC PHOSPHATE; GOLDENSEAL; LYCOPODIUM CLAVATUM SPORE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORUS; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; STRYCHNOS NUX-VOMICA SEED
**Strength:** 6; 6; 6; 6; 6; 3; 6; 6; 6; 6; 6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
**Dosage form:** Solution
**Route:** Sublingual
**Labeler:** DNA Labs, Inc.
**Marketing category:** UNAPPROVED HOMEOPATHIC
**Pharmacologic class:** Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]
/api/v1/systems/ndc_fda/nodes/58264-0163Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.